Arsenic induces tumor necrosis factor α release and tumor necrosis factor receptor 1 signaling in T helper cell apoptosis

被引:49
作者
Yu, HS
Liao, WT
Chang, KL
Yu, CL
Chen, GS
机构
[1] Kaohsiung Med Univ, Dept Dermatol, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Dept Biochem, Kaohsiung 807, Taiwan
[3] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10018, Taiwan
[4] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10018, Taiwan
关键词
cytokine; cytokine receptor; cytotoxicity; lymphocytes; sodium arsenite;
D O I
10.1046/j.1523-1747.2002.00475.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Long-term exposure to arsenic induces arsenical cancers in human beings. Arsenic has been shown to induce apoptosis in a variety of cell systems. Previous studies revealed that patients with arsenic-induced Bowen's disease showed a defective cell-mediated immunity and decreased percentages of T cell and T helper cell subpopulations in peripheral mononuclear cells. The purpose of this study was to investigate the effects of arsenic on T cell survival and function in mononuclear cells. Arsenic concentrations higher than 1 muM induced tumor necrosis factor alpha release from mononuclear cells and caused a cytotoxic effect on T cells. When exposed to higher concentrations of arsenic, apoptosis was induced. CD4+ cells were the major apoptoic population in mononuclear cells. Tumor necrosis factor receptor 1 expression on CD4+ cells, but not Fas/FasL, was significantly enhanced by arsenic treatment compared to other mononuclear cells. Increased expressions of tumor necrosis factor receptor 1 related death domain proteins and activated caspases were observed. These findings indicate that tumor necrosis factor receptor 1 signaling is the major pathway in arsenic-induced T helper cell apoptosis.
引用
收藏
页码:812 / 819
页数:8
相关论文
共 47 条
[1]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[2]   CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS [J].
BRUNNER, T ;
MOGIL, RJ ;
LAFACE, D ;
YOO, NJ ;
MAHBOUBI, A ;
ECHEVERRI, F ;
MARTIN, SJ ;
FORCE, WR ;
LYNCH, DH ;
WARE, CF ;
GREEN, DR .
NATURE, 1995, 373 (6513) :441-444
[3]  
Chen C. J., 1997, ARSENIC EXPOSURE HLT, P232
[4]  
CHEN CJ, 1985, CANCER RES, V45, P5895
[5]  
Chen GQ, 1996, BLOOD, V88, P1052
[6]   Caspases: the executioners of apoptosis [J].
Cohen, GM .
BIOCHEMICAL JOURNAL, 1997, 326 :1-16
[7]   Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches [J].
Constant, SL ;
Bottomly, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :297-322
[8]   Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes [J].
Cuvillier, O ;
Rosenthal, DS ;
Smulson, ME ;
Spiegel, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :2910-2916
[9]   Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway [J].
Dbaibo, GS ;
Perry, DK ;
Gamard, CJ ;
Platt, R ;
Poirier, GG ;
Obeid, LM ;
Hannun, YA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :481-490
[10]   A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [J].
Enari, M ;
Sakahira, H ;
Yokoyama, H ;
Okawa, K ;
Iwamatsu, A ;
Nagata, S .
NATURE, 1998, 391 (6662) :43-50